Personal information

Verified email domains

France

Activities

Employment (3)

ICANS Institut de cancérologie Strasbourg Europe: Strasbourg, Grand-Est, FR

2019-11-19 to present | Pharmacist (Bas-Rhin)
Employment
Source: Self-asserted source
Pierre COLIAT

Centre Paul Strauss: Strasbourg, Alsace, FR

2014-11-01 to present | Pharmacist (Pharmacy)
Employment
Source: Self-asserted source
Pierre COLIAT

Centre Paul Strauss: Strasbourg, Alsace, FR

2014-11-01 to present | Pharmacist (Tumor Biology Laboratory)
Employment
Source: Self-asserted source
Pierre COLIAT

Works (8)

Influence of pneumatic transportation on the stability of monoclonal antibodies

Scientific Reports
2023-12-10 | Journal article
Part of ISSN: 2045-2322
Contributors: Pierre Coliat; Stéphane Erb; Hélène Diemer; Dan Karouby; Tristan Martin; Mainak Banerjee; Chen Zhu; Martin Demarchi; Sarah Cianférani; Alexandre Detappe et al.
Source: Self-asserted source
Pierre COLIAT

Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects

Small
2023-03 | Journal article
Contributors: Marie‐Charlotte Diringer; Pierre Coliat; Clélia Mathieu; Nina Laurent; Carole Mura; Mainak Banerjee; Chen Zhu; Anna Grabowska; Alison Ritchie; Philip Clarke et al.
Source: check_circle
Crossref

Clinical validation of pneumatic transportation systems for monoclonal antibodies

2023-03-27 | Preprint
Contributors: Pierre Coliat; Stéphane Erb; Hélène Diemer; Dan Karouby; Mainak Banerjee; Chen Zhu; Martin Demarchi; Sarah Cianférani; Alexandre Detappe; Xavier Pivot
Source: check_circle
Crossref

Constitutive or Induced HIF-2 Addiction is Involved in Resistance to Anti-EGFR Treatment and Radiation Therapy in HNSCC

Cancers
2019-10-21 | Journal article
Contributors: Pierre Coliat; Ludivine Ramolu; Jérémie Jégu; Christian Gaiddon; Alain C. Jung; Erwan Pencreach
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53

Cancer Letters
2019-01 | Journal article
Contributors: Vania Vidimar; Cynthia Licona; Ricardo Cerón-Camacho; Eric Guerin; Pierre Coliat; Aina Venkatasamy; Moussa Ali; Dominique Guenot; Ronan Le Lagadec; Alain C. Jung et al.
Source: check_circle
Crossref

Is antihistaminergic H2 really useful in prevention of hypersensitivity induced by paclitaxel?

2016-08 | Journal article
Contributors: Slimano F; Coliat P; Perotin JM; Vella-Boucaud J; Mongaret C; Bouché O
Source: Self-asserted source
Pierre COLIAT via Europe PubMed Central

Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature

Oral Oncology
2015-09 | Journal article
Contributors: Elodie Hanns; Sylvie Job; Pierre Coliat; Christine Wasylyk; Ludivine Ramolu; Erwan Pencreach; Meggy Suarez-Carmona; Michael Herfs; Sonia Ledrappier; Christine Macabre et al.
Source: check_circle
Crossref

[Mechanisms of pharmacokinetic drug-drug interactions].

2010-02 | Journal article
Contributors: Levêque D; Lemachatti J; Nivoix Y; Coliat P; Santucci R; Ubeaud-Séquier G; Beretz L; Vinzio S
Source: Self-asserted source
Pierre COLIAT via Europe PubMed Central

Peer review (1 review for 1 publication/grant)

Review activity for Annales pharmaceutiques françaises. (1)